Enanta Pharmaceuticals
ENTA
#8621
Rank
NZ$0.46 B
Marketcap
NZ$15.82
Share price
-18.56%
Change (1 day)
-30.24%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$0.54 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are NZ$0.54 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-09-30NZ$0.48 B-18.4%
2024-09-30NZ$0.59 B-23.02%
2023-09-30NZ$0.77 B15.78%
2022-09-30NZ$0.66 B4.68%
2021-09-30NZ$0.63 B-13.32%
2020-09-30NZ$0.73 B-6.16%
2019-09-30NZ$0.78 B25.07%
2018-09-30NZ$0.62 B37.69%
2017-09-30NZ$0.45 B17.23%
2016-09-30NZ$0.38 B0.62%
2015-09-30NZ$0.38 B93.47%
2014-09-30NZ$0.19 B41.14%
2013-09-30NZ$0.14 B123.79%
2012-09-30NZ$63.01 M85.31%
2011-09-30NZ$34 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$359.31 B 66,402.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$213.21 B 39,361.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$245.90 B 45,413.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$49.91 B 9,137.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$236.23 B 43,623.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$161.56 B 29,802.65%๐Ÿ‡บ๐Ÿ‡ธ USA